← back to search

Eric B. Fauman

Pfizer (United States) · US
Area of research
Genetics · Molecular Biology
Research interest
Research interests include Genetic Associations and Epidemiology, Bioinformatics and Genomic Networks, Metabolomics and Mass Spectrometry Studies, and Genetic Mapping and Diversity in Plants and Animals.
h-index
44
citations
11,929
works
118
NIH funding
primary concept
Biology
email

Recent publications

Plasma proteomic associations with genetics and health in the UK Biobank
Nature 2023cited by 1,424position: middledoi
The Type 2 Diabetes Knowledge Portal: An open access genetic resource dedicated to type 2 diabetes and related traits
Cell Metabolism 2023cited by 131position: middledoi
Genome-wide association studies of metabolites in Finnish men identify disease-relevant loci
Nature Communications 2022cited by 190position: middledoi
Rare and common genetic determinants of metabolic individuality and their effects on human health
Nature Medicine 2022cited by 154position: middledoi
An effector index to predict target genes at GWAS loci
Human Genetics 2022cited by 74position: middledoi
Integrating transcriptomics, metabolomics, and GWAS helps reveal molecular mechanisms for metabolite levels and disease risk
The American Journal of Human Genetics 2022cited by 60position: middledoi
The genetic regulation of protein expression in cerebrospinal fluid
EMBO Molecular Medicine 2022cited by 53position: middledoi
Publisher Correction: Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals
Nature Genetics 2021cited by 3position: middledoi
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals
Nature Metabolism 2020cited by 766position: middledoi
Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals
Nature Genetics 2020cited by 236position: middledoi
Characterising a healthy adult with a rare HAO1 knockout to support a therapeutic strategy for primary hyperoxaluria
eLife 2020cited by 62position: middledoi
A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes
Diabetes 2018cited by 197position: middledoi
Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease
PLoS Genetics 2017cited by 375position: middledoi
Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms
Nature Genetics 2017cited by 320position: middledoi
The Genetic Landscape of Renal Complications in Type 1 Diabetes
Journal of the American Society of Nephrology 2016cited by 133position: middledoi
An atlas of genetic influences on human blood metabolites
Nature Genetics 2014cited by 1,636position: middledoi
Biomarkers for Type 2 Diabetes and Impaired Fasting Glucose Using a Nontargeted Metabolomics Approach
Diabetes 2013cited by 425position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Siyuan Chen · Ningbo University1 papers (2022–2022)Noël P. Burtt · Broad Institute1 papers (2022–2022)Kirsten Ward · Centers for Disease Control and Prevention1 papers (2013–2013)M. Julia Brosnan · Pfizer (United States)1 papers (2013–2013)Shorena Janelidze · Lund University1 papers (2022–2022)Karen A. Hunt · Icahn School of Medicine at Mount Sinai1 papers (2020–2020)David V. Erbe · Johns Hopkins Medicine1 papers (2020–2020)Ann-Kristin Petersen · University of Regensburg1 papers (2013–2013)Tracy L. McGregor · Vanderbilt University1 papers (2020–2020)So–Youn Shin · University of Bristol1 papers (2013–2013)Tim D. Spector · US Forest Service1 papers (2013–2013)Daniel G. MacArthur · Garvan Institute of Medical Research1 papers (2020–2020) · 1 papers (2022–2022)Paul Nioi · Alnylam Pharmaceuticals (United States)1 papers (2020–2020)John Morris · University of Toronto1 papers (2022–2022)Chris Griffiths · Queen Mary University of London1 papers (2020–2020)Celia M.T. Greenwood · McGill University1 papers (2022–2022)Jason Flannick · Broad Institute1 papers (2022–2022)Nicholas A. Vulpescu · Johns Hopkins Medicine1 papers (2022–2022)Craig Hyde · Science for Life Laboratory1 papers (2013–2013)